Replies to post #683 on Enanta Pharmaceuticals Inc (ENTA)

[willyw]

I'm under the impression the 25% referred to ritonavir boosting, not the riba dosing;

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107257955

------------------------
The riba dosing is weight based, but as with many other DAA programs the dosing can often be reduced/ ended early (without going full term) without compromising SVR rates.
I believe that there may even be a paper presented on that subject at AASLD.